Literature DB >> 16740635

Neuregulins mediate calcium-induced glucose transport during muscle contraction.

Carles Cantó1, Alexander V Chibalin, Brian R Barnes, Stephan Glund, Elisabet Suárez, Jeffrey W Ryder, Manuel Palacín, Juleen R Zierath, Antonio Zorzano, Anna Gumà.   

Abstract

Neuregulin, a growth factor involved in myogenesis, has rapid effects on muscle metabolism. In a manner analogous to insulin and exercise, neuregulins stimulate glucose transport through recruitment of glucose transporters to surface membranes in skeletal muscle. Like muscle contraction, neuregulins have additive effects with insulin on glucose uptake. Therefore, we examined whether neuregulins are involved in the mechanism by which muscle contraction regulates glucose transport. We show that caffeine-induced increases in cytosolic Ca2+ mediate a metalloproteinase-dependent release of neuregulins, which stimulates tyrosine phosphorylation of ErbB4 receptors. Activation of ErbB4 is necessary for Ca2+-derived effects on glucose transport. Furthermore, blockage of ErbB4 abruptly impairs contraction-induced glucose uptake in slow twitch muscle fibers, and to a lesser extent, in fast twitch muscle fibers. In conclusion, we provide evidence that contraction-induced activation of neuregulin receptors is necessary for the stimulation of glucose transport and a key element of energetic metabolism during muscle contraction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740635     DOI: 10.1074/jbc.M600475200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Exercise-stimulated glucose uptake - regulation and implications for glycaemic control.

Authors:  Lykke Sylow; Maximilian Kleinert; Erik A Richter; Thomas E Jensen
Journal:  Nat Rev Endocrinol       Date:  2016-10-14       Impact factor: 43.330

2.  ErbB4 deletion predisposes to development of metabolic syndrome in mice.

Authors:  Fenghua Zeng; Yinqiu Wang; Lance A Kloepfer; Suwan Wang; Raymond C Harris
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-06-26       Impact factor: 4.310

3.  Endothelial ErbB4 deficit induces alterations in exploratory behavior and brain energy metabolism in mice.

Authors:  Gang Wu; Xiu-Xiu Liu; Nan-Nan Lu; Qi-Bing Liu; Yun Tian; Wei-Feng Ye; Guo-Jun Jiang; Rong-Rong Tao; Feng Han; Ying-Mei Lu
Journal:  CNS Neurosci Ther       Date:  2017-04-18       Impact factor: 5.243

4.  Exercise training and return to a well-balanced diet activate the neuregulin 1/ErbB pathway in skeletal muscle of obese rats.

Authors:  Gaël Ennequin; Nathalie Boisseau; Kevin Caillaud; Vivien Chavanelle; Maude Gerbaix; Lore Metz; Monique Etienne; Stéphane Walrand; Aurélie Masgrau; Christelle Guillet; Daniel Courteix; Airu Niu; Yi-Ping Li; Fréderic Capel; Pascal Sirvent
Journal:  J Physiol       Date:  2015-05-14       Impact factor: 5.182

5.  Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.

Authors:  Manisha Gupte; Hind Lal; Firdos Ahmad; Douglas B Sawyer; Michael F Hill
Journal:  J Card Fail       Date:  2017-09-04       Impact factor: 5.712

6.  Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss.

Authors:  José Manuel Fernández-Real; Javier A Menendez; Gema Frühbeck; José María Moreno-Navarrete; Alejandro Vazquez-Martín; Wifredo Ricart
Journal:  Nutr Metab (Lond)       Date:  2010-02-25       Impact factor: 4.169

7.  Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells.

Authors:  German Perdomo; Maria A Martinez-Brocca; Bankim A Bhatt; Nicholas F Brown; Robert M O'Doherty; Adolfo Garcia-Ocaña
Journal:  J Biol Chem       Date:  2008-03-24       Impact factor: 5.157

8.  A myosin II ATPase inhibitor reduces force production, glucose transport, and phosphorylation of AMPK and TBC1D1 in electrically stimulated rat skeletal muscle.

Authors:  David R Blair; Katsuhiko Funai; George G Schweitzer; Gregory D Cartee
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-03       Impact factor: 4.310

9.  Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice.

Authors:  Takatomo Arai; Yumika Ono; Yujiro Arimura; Keimon Sayama; Tomohiro Suzuki; Satoko Shinjo; Mai Kanai; Shin-Ichi Abe; Kentaro Semba; Nobuhito Goda
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

10.  Neuregulin 1 Improves Glucose Tolerance in db/db Mice.

Authors:  Gaël Ennequin; Nathalie Boisseau; Kevin Caillaud; Vivien Chavanelle; Monique Etienne; Xinyan Li; Pascal Sirvent
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.